Similar Articles
1211 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
1212 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
1213 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
1214 Latest developments in precancerous lesions of hepatocellular carcinoma
1215 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
1216 Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo
1217 Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma
1218 New advances in hepatocellular carcinoma
1219 Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy
1220 Incidence and risk factors for early renal dysfunction after liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA